Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Yoshida

Showing results (271-280 of 316) with videos related to

Pageof 32
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 24, 2022
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosisYuki Tahata, Ryotaro Sakamori, Ryoko Yamada, et al.
BMC Gastroenterology|May 1, 2026
Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliterationKazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, et al.
World Neurosurgery|December 24, 2023
Comparative Analysis of Microendoscopic and Open Laminectomy for Single-Level Lumbar Spinal Stenosis at L1-L2 or L2-L3Yukimasa Yamato, Kosei Nagata, Naohiro Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 6, 2016
Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infectionNaoki Morishita, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Medical Virology|March 19, 2016
Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapyYuki Tahata, Naoki Hiramatsu, Tsugiko Oze, et al.
The Journal of Dermatology|July 20, 2024
Real-world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational studyChika Ohata, Hisataka Anezaki, Tetsuji Yanase, et al.
Gastro Hep Advances|August 12, 2024
Distinction of Drug-Induced Liver Injury From Autoimmune Hepatitis in Patients With Acute Liver Injury: Proposal of a Combination of Diagnostic ScoresKeisuke Kakisaka, Nobuaki Nakayama, Kotaro Kumagai, et al.
Journal of Hepatology|December 15, 2010
Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapyTsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 16, 2022
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter studyYuya Seko, Hirokazu Takahashi, Hidenori Toyoda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 12, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLDYuya Seko, Taeang Arai, Hirokazu Takahashi, et al.
Pageof 32

Showing results (271-280 of 316) with videos related to

Sort By:
Pageof 32
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 24, 2022
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosisYuki Tahata, Ryotaro Sakamori, Ryoko Yamada, et al.
BMC Gastroenterology|May 1, 2026
Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliterationKazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, et al.
World Neurosurgery|December 24, 2023
Comparative Analysis of Microendoscopic and Open Laminectomy for Single-Level Lumbar Spinal Stenosis at L1-L2 or L2-L3Yukimasa Yamato, Kosei Nagata, Naohiro Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 6, 2016
Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infectionNaoki Morishita, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Medical Virology|March 19, 2016
Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapyYuki Tahata, Naoki Hiramatsu, Tsugiko Oze, et al.
The Journal of Dermatology|July 20, 2024
Real-world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational studyChika Ohata, Hisataka Anezaki, Tetsuji Yanase, et al.
Gastro Hep Advances|August 12, 2024
Distinction of Drug-Induced Liver Injury From Autoimmune Hepatitis in Patients With Acute Liver Injury: Proposal of a Combination of Diagnostic ScoresKeisuke Kakisaka, Nobuaki Nakayama, Kotaro Kumagai, et al.
Journal of Hepatology|December 15, 2010
Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapyTsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 16, 2022
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter studyYuya Seko, Hirokazu Takahashi, Hidenori Toyoda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 12, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLDYuya Seko, Taeang Arai, Hirokazu Takahashi, et al.
Pageof 32